Clinical Trials

Boston Scientific Begins Clinical Trial Enrollment For OMEGA™ Platinum Chromium Stent System

admin — Wed, 08 Feb 2012 03:58:25 +0000

Boston Scientific Corporation (NYSE: BSX) has started patient enrollment in the OMEGA clinical trial, designed to evaluate the safety and effectiveness of the Company’s OMEGA™ Platinum Chromium Bare-Metal Coronary Stent System in treating patients with a single coronary artery lesion. This prospective, single-arm trial will enroll 328 patients at 40 sites in the U.S. and Europe…

View full post on Clinical Trials / Drug Trials News From Medical News Today

Boston Scientific Begins Clinical Trial Enrollment For OMEGA™ Platinum Chromium Stent System Boston Scientific Corporation (NYSE: BSX) has started patient enrollment in the OMEGA clinical trial, designed ...
Abbott Enrolls First U.S. Patient In Global EXCEL Trial Comparing XIENCE To Coronary Artery Bypass Surgery Abbott (NYSE: ABT) announced it has begun enrolling U.S. patients in the EXCEL (Evaluation of ...
InfraReDx Initiates A Randomized Clinical Trial Of LipiScan IVUS™ Coronary Imaging Guidance To Prevent Heart Attacks During Stenting InfraReDx, Inc., a medical device company providing intelligent cardiovascular diagnostic imaging technologies, today announced enrollment ...
InfraReDx Initiates A Randomized Clinical Trial Of LipiScan IVUS™ Coronary Imaging Guidance To Prevent Heart Attacks During Stenting InfraReDx, Inc., a medical device company providing intelligent cardiovascular diagnostic imaging technologies, today announced enrollment ...
Zyga Technology, Inc. Announces Start Of European Enrollment For The GLYDER™ Facet Resurfacing System Clinical Study Zyga Technology, Inc. announced that the first European patients were enrolled and treated in its ...

Boston Scientific Begins Clinical Trial Enrollment For OMEGA™ Platinum Chromium Stent System

admin — Wed, 08 Feb 2012 03:58:25 +0000

View full post on Clinical Trials / Drug Trials News From Medical News Today

Boston Scientific Begins Clinical Trial Enrollment For OMEGA™ Platinum Chromium Stent System Boston Scientific Corporation (NYSE: BSX) has started patient enrollment in the OMEGA clinical trial, designed ...
Abbott Enrolls First U.S. Patient In Global EXCEL Trial Comparing XIENCE To Coronary Artery Bypass Surgery Abbott (NYSE: ABT) announced it has begun enrolling U.S. patients in the EXCEL (Evaluation of ...
InfraReDx Initiates A Randomized Clinical Trial Of LipiScan IVUS™ Coronary Imaging Guidance To Prevent Heart Attacks During Stenting InfraReDx, Inc., a medical device company providing intelligent cardiovascular diagnostic imaging technologies, today announced enrollment ...
InfraReDx Initiates A Randomized Clinical Trial Of LipiScan IVUS™ Coronary Imaging Guidance To Prevent Heart Attacks During Stenting InfraReDx, Inc., a medical device company providing intelligent cardiovascular diagnostic imaging technologies, today announced enrollment ...
Zyga Technology, Inc. Announces Start Of European Enrollment For The GLYDER™ Facet Resurfacing System Clinical Study Zyga Technology, Inc. announced that the first European patients were enrolled and treated in its ...

Clinical Trials Likely Soon For Gene Therapy To Reverse Heart Failure

admin — Mon, 06 Feb 2012 13:57:29 +0000

A promising gene therapy developed, in part, at Thomas Jefferson University’s Center for Translational Medicine to prevent and reverse congestive heart failure is on the verge of clinical trials, after years of proving itself highly effective in the lab and a large animal study…

View full post on Clinical Trials / Drug Trials News From Medical News Today

Clinical Trials Likely Soon For Gene Therapy To Reverse Heart Failure A promising gene therapy developed, in part, at Thomas Jefferson University's Center for Translational Medicine ...
In Global Heart Failure Trials Outcomes Vary By Geographic Region A comparison of several international clinical trials of beta-blocker drugs has shown there are notable ...
Mesoblast Receives Clearance To Begin First European Trial Of Allogeneic Or ‘Off-The-Shelf’ Stem Cell Treatment For Heart Attacks Global regenerative medicine company, Mesoblast Limited, (ASX: MSB), announced that it had received clearance from ...
Genethon And Children’s Hospital Boston Get FDA Approval For A Wiskott Aldrich Gene Therapy Trial The U.S. Food & Drug Administration (FDA) approved the launching in the U.S. of a ...
EGT Transfers CGMP Vector For Gene Therapy Trial Errant Gene Therapeutics, LLC ("EGT"), a pioneering boutique drug development firm specializing in Rare Diseases, ...

Clinical Trials Likely Soon For Gene Therapy To Reverse Heart Failure

admin — Mon, 06 Feb 2012 13:57:29 +0000

View full post on Clinical Trials / Drug Trials News From Medical News Today

Clinical Trials Likely Soon For Gene Therapy To Reverse Heart Failure A promising gene therapy developed, in part, at Thomas Jefferson University's Center for Translational Medicine ...
In Global Heart Failure Trials Outcomes Vary By Geographic Region A comparison of several international clinical trials of beta-blocker drugs has shown there are notable ...
Mesoblast Receives Clearance To Begin First European Trial Of Allogeneic Or ‘Off-The-Shelf’ Stem Cell Treatment For Heart Attacks Global regenerative medicine company, Mesoblast Limited, (ASX: MSB), announced that it had received clearance from ...
Genethon And Children’s Hospital Boston Get FDA Approval For A Wiskott Aldrich Gene Therapy Trial The U.S. Food & Drug Administration (FDA) approved the launching in the U.S. of a ...
EGT Transfers CGMP Vector For Gene Therapy Trial Errant Gene Therapeutics, LLC ("EGT"), a pioneering boutique drug development firm specializing in Rare Diseases, ...

FDA Clears X-22 IND For Phase II-B Smoking Cessation Clinical Trial

admin — Sat, 04 Feb 2012 23:58:33 +0000

22nd Century Group, Inc. (OTCBB: XXII), a company focused on smoking cessation and tobacco harm reduction products, today announced that the U.S. Food & Drug Administration (FDA) has cleared an Investigational New Drug (IND) Application to conduct a Phase II-B clinical trial using X-22, a prescription smoking cessation aid in development…

View full post on Clinical Trials / Drug Trials News From Medical News Today

FDA Clears X-22 IND For Phase II-B Smoking Cessation Clinical Trial 22nd Century Group, Inc. (OTCBB: XXII), a company focused on smoking cessation and tobacco harm ...
Idera Reports Clinical Hold On Proposed Phase 2 Clinical Trial Of IMO-3100 Idera Pharmaceuticals (Nasdaq: IDRA) today announced the receipt of a verbal communication from the U.S. ...
Idera Reports Clinical Hold On Proposed Phase 2 Clinical Trial Of IMO-3100 Idera Pharmaceuticals (Nasdaq: IDRA) today announced the receipt of a verbal communication from the U.S. ...
KFDA Grants IND Approval For Phase III MACSI Study Of DP-b99 In Korea D-Pharm Ltd., (TASE: DPRM) announced that the Korean Food & Drug Administration (KFDA) approved the ...
Marshall Edwards Announces Initiation Of Phase I Clinical Trial Of Lead Oncology Drug Candidate ME-143 Marshall Edwards, Inc. (Nasdaq: MSHL), an oncology company focused on the clinical development of novel ...

Clinical Trials

Boston Scientific Begins Clinical Trial Enrollment For OMEGA™ Platinum Chromium Stent System

Related Posts:

Boston Scientific Begins Clinical Trial Enrollment For OMEGA™ Platinum Chromium Stent System

Related Posts:

Clinical Trials Likely Soon For Gene Therapy To Reverse Heart Failure

Related Posts:

Clinical Trials Likely Soon For Gene Therapy To Reverse Heart Failure

Related Posts:

FDA Clears X-22 IND For Phase II-B Smoking Cessation Clinical Trial

Related Posts: